NH

Nishant Hitendrakumar Sanghavi

Active Director Designated Partner DIN 10952414
DIN 10952414 First appointment Feb 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Nishant Hitendrakumar Sanghavi

Data last updated:

Nishant Hitendrakumar Sanghavi is a Designated Partner at Unveilm Cancer Associates Llp (since 2025).

DIN 10952414
Primary Designation Designated Partner
First Appointment 17 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner17 Feb 20252025Active

Board colleagues of Nishant Hitendrakumar Sanghavi

Directorship timeline

Open interactive timeline →
Unveilm Cancer Associates Llp
Premium access

Shareholding and investment profile for Nishant Hitendrakumar Sanghavi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nishant Hitendrakumar Sanghavi

Nishant Hitendrakumar Sanghavi currently holds 1 directorship: Unveilm Cancer Associates Llp (Designated Partner, since 17 Feb 2025).

Nishant Hitendrakumar Sanghavi was first appointed on 17 Feb 2025 as Designated Partner at Unveilm Cancer Associates Llp.

The current boards of Nishant Hitendrakumar Sanghavi's companies include Mohit Panchabhai Korat (Unveilm Cancer Associates Llp), Nikunjkumar Naranbhai Patel (Unveilm Cancer Associates Llp), Urvish Kamlesh Shah (Unveilm Cancer Associates Llp), Veer Ramanlal Shah (Unveilm Cancer Associates Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available